C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2004
12/07/2004	US6828116 Energy transfer assay method and reagent
12/02/2004	WO2004104205A2 Enzymatic preparation of chiral indole esters
12/02/2004	WO2004103970A1 Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
12/02/2004	WO2004103969A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof, and application in the synethesis of perindopril
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	US20040242668 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242563 potent, selective and safe inhibitors of Ca2+-activated potassium channel (Gardos channel) of erythrocytes, particularly sickle erythrocytes, and/or of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
12/02/2004	US20040241095 Complex containing cyanine dyes; supplying to target tumor cells
12/02/2004	CA2526013A1 Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
12/01/2004	EP1482378A1 Electrophotographic organophotoreceptors with charge transport compounds
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481036A1 Phosphorescent compositions and organic light emitting devices containing them
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480977A2 Substituted aryl compounds for treatment of disease
12/01/2004	EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP1480683A2 Near infrared fluorescent contrast agent and method for fluorescence imaging
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004	CN1550540A Biphenyl derivatives and organic electroluminescent device employing the same
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
12/01/2004	CN1177835C Substituted benzoylcyclohexandiones
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825354 Osteoporosis; rheumatic diseases
11/30/2004	US6825235 Synthesis of taxol enhancers
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825195 Fluorescent group-containing carbodiimide compound and process for producing the compound
11/30/2004	US6824760 Imaging agents, precursors thereof and methods of manufacture
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101530A1 A method for producing diverse set of dithioate compounds
11/25/2004	WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004	WO2004101516A2 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
11/25/2004	WO2004101515A1 A process for the preparation of compounds having an ace inhibitory action
11/25/2004	WO2004101495A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
11/25/2004	WO2004101491A1 Arylamine compound and organic electroluminescence device containing the same
11/25/2004	WO2004100865A2 New benzimidazole derivatives
11/25/2004	WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004083194B1 Blue light-emitting compound, method for producing same and light-emitting device utilizing same
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004069133A3 N-monoacylated o-phenylenediamines as anti -cancer agents
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236115 Synthesis of cyclopentadiene derivatives
11/25/2004	US20040236110 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy
11/25/2004	US20040235932 Ophthalmic pharmaceutical compositions
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235929 Antiestrogenic and antitumorigenic activities; cancer
11/25/2004	US20040235928 Process for the preparation of optically active amines or salts thereof
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004	US20040235899 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235809 Epoxy steroidal aldosterone antagonist and beta-adremergic antagonist combination therepy for treatment of congestive heart failure
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040234814 Blue light-emitting compounds, blue light-emitting polymers, processes of preparing the blue light-emitting compounds and luminescent element including the blue light-emitting polymers
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	US20040233760 Magnetic random access memory array with coupled soft adjacent magnetic layer
11/25/2004	US20040231073 Method of mass-colouring synthetic materials
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525447A1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
11/25/2004	CA2525006A1 `(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
11/24/2004	EP1478635A1 Process for the production of citalopram
11/24/2004	EP1478626A2 Guanidino compounds
11/24/2004	EP1478363A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	EP0904348B1 Process for the preparation of amino alcohols and derivatives thereof
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1548421A Tilmisartan salt and its prepn
11/24/2004	CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822094 Spiro compounds and their use
11/23/2004	US6822057 Olefin polymerization catalysts derived from Group-15 cationic compounds and processes using them
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821960 Glucagon antagonists/inverse agonists

1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 458